Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 18:36:28 GMT 2025
by
admin
on
Tue Apr 01 18:36:28 GMT 2025
|
| Protein Type | ENZYME |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
4APO0P2BE7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4APO0P2BE7
Created by
admin on Tue Apr 01 18:36:28 GMT 2025 , Edited by admin on Tue Apr 01 18:36:28 GMT 2025
|
PRIMARY | |||
|
O60341
Created by
admin on Tue Apr 01 18:36:28 GMT 2025 , Edited by admin on Tue Apr 01 18:36:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
IRREVERSIBLE INHIBITOR
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET | |||
|
RADIOLIGAND->TARGET |
|
||
|
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
PRECLINICAL
IC50
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
99.33% INHIBITION @ 0.4 MICROMOLAR
|
||
|
INHIBITOR -> TARGET |
IRREVERSIBLE INHIBITOR
IC50
|
||
|
INHIBITOR -> TARGET |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_135] | TYROSINE O-PHOSPHATE | 2R86C98KDX | |||
| AMINO ACID SUBSTITUTION | [1_126] [1_131] [1_137] [1_166] [1_849] | DEXFOSFOSERINE | VI4F0K069V | |||
| AMINO ACID SUBSTITUTION | [1_59] [1_104] | THREONINE PHOSPHATE | 3L4WX7B1EI |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT | CHEMICAL |
|